Higher levels of cell apoptosis and abnormal E-cadherin expression in the urothelium are associated with inflammation in patients with interstitial cystitis/painful bladder syndrome

BJU International

Volumn 108, Issue 2 B, 2011, Pages

  Shie, Jia Heng ^a   Kuo, Hann Chorng ^a  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

apoptosis; inflammation; interstitial cystitis; painful bladder syndrome; urothelial dysfunction

Indexed keywords

KI 67 ANTIGEN; TRYPTASE; UVOMORULIN;

APOPTOSIS; ARTICLE; BLADDER; CELL ACTIVATION; CELL COUNT; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; FLUORESCENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; INTERSTITIAL CYSTITIS; MAST CELL; NICK END LABELING; PAIN ASSESSMENT; PAINFUL BLADDER SYNDROME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; UROGENITAL TRACT INFLAMMATION; VISUAL ANALOG SCALE;

EID: 79954597200     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09911.x     Document Type: Article

References (25)

1. Homma Y, Ueda T, Tomoe H, et al,. Clinical guidelines for interstitial cystitis and hypersensitive bladder syndrome. Int J Urol 2009; 16: 597-615
2. Bouchelouche K, Nordling J,. Recent developments in the management of interstitial cystitis. Curr Opin Urol 2003; 13: 309-13 (Pubitemid 36900670)
3. Keay S,. Cell signaling in interstitial cystitis/painful bladder syndrome. Cell Signal 2008; 20: 2174-9
4. Van De Merwe JP, Arendsen HJ,. Interstitial cystitis: a review of immunological aspects of the aetiology and pathogenesis, with a hypothesis. BJU Int 2000; 85: 995-9 (Pubitemid 30240586)
5. Sant GR, Kempuraj D, Marchand JE, Theoharides TC,. The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis. Urology 2007; 69: 34-40
6. Saban R, Saban MR, Maier J, et al,. Urothelial expression of neuropilins and VEGF receptors in control and interstitial cystitis patients. Am J Physiol Renal Physiol 2008; 295: F1613-23
7. Southgate J, Varley CL, Garthwaite MA, et al,. Differentiation potential of urothelium from patients with benign bladder dysfunction. BJU Int 2007; 99: 1506-16 (Pubitemid 47164804)
8. Parsons CL,. The role of the urinary epithelium in the pathogenesis of interstitial cystitis/prostatitis/urethritis. Urology 2007; 69: 9-16
9. Soler R, Bruschini H, Freire MP, Alves MT, Srougi M, Ortiz V,. Urine is necessary to provoke bladder inflammation in protamine sulfate induced urothelial injury. J Urol 2008; 180: 1527-31
10. Teichman JM, Moldwin R,. The role of the bladder surface in interstitial cystitis/painful bladder syndrome. Can J Urol 2007; 14: 3599-607
11. Neuhaus J, Heinrich M, Schlichting N, et al,. [Structure and function of suburothelial myofibroblasts in the human urinary bladder under normal and pathological conditions]. Urologe A 2007; 46: 1197-202 [Article in German] (Pubitemid 47459139)
12. Slobodov G, Feloney M, Gran C, Kyker KD, Hurst RE, Culkin DJ,. Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis. J Urol 2004; 171: 1554-8 (Pubitemid 38365417)
13. O'Leary MP, Sant GR, Fowler FJ Jr, Whitmore KE, Spolarich-Kroll J,. The interstitial cystitis symptom index and problem index. Urology 1997; 49: 58-63 (Pubitemid 27193953)
14. Kaczmarek E, Górna A, Majewski P,. Techniques of image analysis for quantitative immunohistochemistry. Rocz Akad Med Bialymst 2004; 49 (Suppl. 1): 155-8
15. Steers WD, Tuttle JB,. Mechanisms of Disease: the role of nerve growth factor in the pathophysiology of bladder disorders. Nat Clin Pract Urol 2006; 3: 101-10 (Pubitemid 43239267)
16. Chancellor MB, Yoshimura N,. Treatment of interstitial cystitis. Urology 2004; 63: 85-92 (Pubitemid 38317368)
17. Hauser PJ, Dozmorov MG, Bane BL, Slobodov G, Culkin DJ, Hurst RE,. Abnormal expression of differentiation related proteins and proteoglycan core proteins in the urothelium of patients with interstitial cystitis. J Urol 2008; 179: 764-9
18. Zhang CO, Wang JY, Koch KR, Keay S,. Regulation of tight junction proteins and bladder epithelial paracellular permeability by an antiproliferative factor from patients with interstitial cystitis. J Urol 2005; 174: 2382-7 (Pubitemid 41611833)
19. Graham E, Chai TC,. Dysfunction of bladder urothelium and bladder urothelial cells in interstitial cystitis. Curr Urol Rep 2006; 7: 440-6 (Pubitemid 44663234)
20. Dodd LG, Tello J,. Cytologic examination of urine from patients with interstitial cystitis. Acta Cytol 1998; 42: 923-7 (Pubitemid 28357153)
21. Bouchelouche K, Kristensen B, Nordling J, Horn T, Bouchelouche P,. Increased urinary leukotriene E4 and eosinophil protein X excretion in patients with interstitial cystitis. J Urol 2001; 166: 2121-5 (Pubitemid 33065234)
22. Wang ZY, Wang P, Bjorling DE,. Role of mast cells and protease-activated receptor-2 in cyclooxygenase-2 expression in urothelial cells. Am J Physiol Regul Integr Comp Physiol 2009; 297: R1127-35
23. Pece S, Gutkind JS,. Signaling from E-cadherins to the MAPK pathway by the recruitment and activation of epidermal growth factor receptors upon cell-cell contact formation. J Biol Chem 2000; 275: 41227-33 (Pubitemid 32054955)
24. Chuang YC, Fraser MO, Yu Y, Chancellor MB, de Groat WC, Yoshimura N,. The role of bladder afferent pathways in bladder hyperactivity induced by the intravesical administration of nerve growth factor. J Urol 2001; 165: 975-9 (Pubitemid 32156334)
25. Seki S, Sasaki K, Fraser MO, et al,. Immunoneutralization of nerve growth factor in lumbosacral spinal cord reduces bladder hyperreflexia in spinal cord injured rats. J Urol 2002; 168: 2269-74